Home > Annual Financials > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS Financial Statement Analysis
[BOM: 532815|NSE : SMSPHARMA]

The Revenues of SMS PHARMACEUTICALS have increased by 13.30% YoY .
The Earnings Per Share (EPS) of SMS PHARMACEUTICALS has increased by 39.62 % YoY.
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

SMS PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 532815|NSE : SMSPHARMA]

ConsolidatedMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹887 Cr₹783 Cr₹709 Cr₹522 Cr₹520 Cr
Expenses ₹715 Cr₹644 Cr₹593 Cr₹468 Cr₹405 Cr
Operating Profit (Excl OI) ₹172 Cr₹139 Cr₹117 Cr₹55 Cr₹115 Cr
Other Income ₹8.35 Cr₹6.22 Cr₹4.46 Cr₹4.91 Cr₹5.20 Cr
Interest ₹23 Cr₹19 Cr₹24 Cr₹22 Cr₹19 Cr
Depreciation ₹40 Cr₹34 Cr₹32 Cr₹32 Cr₹32 Cr
Profit Before Tax ₹117 Cr₹92 Cr₹66 Cr₹5.35 Cr₹68 Cr
Profit After Tax ₹88 Cr₹67 Cr₹49 Cr₹3.88 Cr₹68 Cr
Consolidated Net Profit ₹102 Cr₹69 Cr₹50 Cr₹-7.06 Cr₹62 Cr
Earnings Per Share (Rs)₹10.89₹7.80₹5.89₹-0.83₹7.35
PAT Margin (%)8.787.966.430.7012.25
ROE(%)12.4911.9110.160.8315.41
ROCE(%)13.3212.5511.733.7912.60
Total Debt/Equity(x)0.460.500.550.550.55

Key Financials

Market Cap : ₹ 4,484.5 Cr
Revenue (TTM) : ₹ 897.8 Cr
Net Profit(TTM) : ₹ 89.5 Cr
EPS (TTM) : ₹ 9.5
P/E (TTM) : 50.1

Industry Peers & Returns1W1M1Y
SMS PHARMACEUTICALS -0.9% 34.7% 60.8%
SUN PHARMACEUTICAL INDUSTRIES -0.3% -3.1% 12.8%
DIVIS LABORATORIES -1.3% 2.2% 57.5%
TORRENT PHARMACEUTICALS -1.3% -2.4% 33.3%
CIPLA 0.2% -2.5% -9.1%
DR REDDYS LABORATORIES 3.3% 6.1% -6.5%
MANKIND PHARMA 3.4% 6.6% -4.8%
LUPIN -1.9% -5.3% 2.8%
ZYDUS LIFESCIENCES 2.2% 0.7% 15.9%


SMS PHARMACEUTICALS Revenues
[BOM: 532815|NSE : SMSPHARMA]

Y-o-Y

13.30 %

5 Yr CAGR

14.29 %

Years Revenues % Change
Mar2026 ₹887 Cr
13.30
Mar2025 ₹783 Cr
10.36
Mar2024 ₹709 Cr
35.86
Mar2023 ₹522 Cr
0.42
Mar2022 ₹520 Cr -


SMS PHARMACEUTICALS Operating Profit
[BOM: 532815|NSE : SMSPHARMA]

Y-o-Y

23.42 %

5 Yr CAGR

10.61 %

Years Operating Profit % Change
Mar2026 ₹172 Cr
23.42
Mar2025 ₹139 Cr
19.04
Mar2024 ₹117 Cr
114.10
Mar2023 ₹55 Cr
-52.42
Mar2022 ₹115 Cr -

Operating Margins
Y-o-Y

8.90 %

5 Yr CAGR

-3.23 %

Years Operating Margin% % Change
Mar2026 19.34%
8.90
Mar2025 17.76%
7.90
Mar2024 16.46%
57.51
Mar2023 10.45%
-52.61
Mar2022 22.05% -

SMS PHARMACEUTICALS Profit After Tax
[BOM: 532815|NSE : SMSPHARMA]

Y-o-Y

47.52 %

5 Yr CAGR

13.15 %

Years Profit After Tax % Change
Mar2026 ₹102 Cr
47.52
Mar2025 ₹69 Cr
38.75
Mar2024 ₹50 Cr
Positive
Mar2023 ₹-7.06 Cr
Negative
Mar2022 ₹62 Cr -

PAT Margins
Y-o-Y

10.30 %

5 Yr CAGR

-7.99 %

Years PAT Margin(%) % Change
Mar2026 8.78 %
10.30
Mar2025 7.96 %
23.79
Mar2024 6.43 %
818.57
Mar2023 0.7 %
-94.29
Mar2022 12.25 % -

SMS PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 532815|NSE : SMSPHARMA]

Y-o-Y

39.62 %

5 Yr CAGR

10.33 %

Years EPS % Change
Mar2026 ₹11
39.62
Mar2025 ₹7.80
32.43
Mar2024 ₹5.89
Positive
Mar2023 ₹-0.83
Negative
Mar2022 ₹7.35 -

SMS PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 532815|NSE : SMSPHARMA]

Y-o-Y

6.14 %

5 Yr CAGR

1.40 %

Years ROCE % Change
Mar2026 13.32%
6.14
Mar2025 12.55%
6.99
Mar2024 11.73%
209.50
Mar2023 3.79%
-69.92
Mar2022 12.6% -

SMS PHARMACEUTICALS Share Price vs Sensex

Current Share Price : ₹478.6
Current MarketCap: ₹ 4,484.5 Cr
Updated EOD on :Sep 29,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

-0.9%

34.7%

60.8%

SENSEX

-2.7%

-5.7%

-11.7%

SMS PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE -0.9% -0.1% 14.5%
No NSE index found

You may also like the below Video Courses


FAQ about SMS PHARMACEUTICALS Financials


How the annual revenues of SMS PHARMACEUTICALS have changed ?

The Revenues of SMS PHARMACEUTICALS have increased by 13.30% YoY .

How the Earnings per Share (EPS) of SMS PHARMACEUTICALS have changed?

The Earnings Per Share (EPS) of SMS PHARMACEUTICALS has increased by 39.62 % YoY .